Cellectar Biosciences Inc [CLRB] stock is trading at $3.99, up 1.79%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CLRB shares have gain 3.10% over the last week, with a monthly amount drifted -5.00%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On September 13, 2019, ROTH Capital initiated with a Buy rating. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $2.70 on December 21, 2016.
Cellectar Biosciences Inc [CLRB] stock has fluctuated between $1.30 and $4.45 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Cellectar Biosciences Inc [NASDAQ: CLRB] shares were valued at $3.99 at the most recent close of the market. An investor can expect a potential return of 200.75% based on the average CLRB price forecast.
Analyzing the CLRB fundamentals
Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at -117.93%, Pretax Profit Margin comes in at -115.16%, and Net Profit Margin reading is -114.6%. To continue investigating profitability, this company’s Return on Assets is posted at -3.14, Equity is 19.31 and Total Capital is 45.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.41.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.81 points at the first support level, and at 3.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.11, and for the 2nd resistance point, it is at 4.22.
Ratios To Look Out For
For context, Cellectar Biosciences Inc’s Current Ratio is 0.81. Also, the Quick Ratio is 0.81, while the Cash Ratio stands at 0.74.
